Despair of repair

Por Stangel, M, Hartung, H
Publicado em 2002

7(th) International Immunoglobulin Conference: Poster Presentations

Por Warnatz, K, Ballow, M, Stangel, M, Bril, V
Publicado no Clin Exp Immunol (2014)

7(th) International Immunoglobulin Conference: Poster Presentations

Por Warnatz, K, Ballow, M, Stangel, M, Bril, V
Publicado no Clin Exp Immunol (2014)

Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis

Por Stangel, M., Boegner, F., Klatt, C., Hofmeister, C., Seyfert, S.
Publicado em 2000

Fumaric Acid and its Esters: An Emerging Treatment for Multiple Sclerosis

Por Moharregh-Khiabani, D, Linker, R.A, Gold, R, Stangel, M
Publicado em 2009

Interferon-β up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis

Por MARCKMANN, S, WIESEMANN, E, HILSE, R, TREBST, C, STANGEL, M, WINDHAGEN, A
Publicado em 2004

Effect of interferon-β1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients

Por Wostradowski, T, Gudi, V, Pul, R, Gingele, S, Lindquist, J A, Stangel, M, Lindquist, S
Publicado no Clin Exp Immunol (2015)

2-Chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells

Por Singh, V, Prajeeth, C K, Gudi, V, Bénardais, K, Voss, E V, Stangel, M
Publicado em 2013